Takeshi Takahashi
Directeur/Bestuurslid bij Pathalys Pharma, Inc.
Actieve functies van Takeshi Takahashi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Directeur/Bestuurslid | - | - |
Loopbaan van Takeshi Takahashi
Eerdere bekende functies van Takeshi Takahashi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2020 | 12-09-2023 |
| Independent Dir/Board Member | 01-05-2020 | 12-09-2023 | |
| TSUGAMI CORPORATION | Operationeel Directeur | 01-04-2020 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-04-2020 | - | |
| Corporate Officer/Principal | - | 01-04-2020 |
Opleiding van Takeshi Takahashi
| Waseda University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Japan | 3 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TSUGAMI CORPORATION | Producer Manufacturing |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Health Technology |
- Beurs
- Insiders
- Takeshi Takahashi
- Ervaring
